
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
PLASMA VIRUS FILTRATION SYSTEM MARKET
INTRODUCTION
A size-based method of virus removal known as a plasma virus filtration system makes use of a polymeric membrane that has been designed to keep virus particles on the surface and within the membrane's pores.
The throughput and the log reduction value (LRV) are typically the critical performance parameters. A membrane barrier is used in virus filtration to keep virus particles in place.
It is a size-based method of removal that keeps virus particles on the membrane's surface and within its pores with a polymeric membrane that has been designed specifically for this purpose.The throughput and the log reduction value (LRV) are typically the critical performance parameters.
Numerous interacting factors, including viral load, protein concentration, the presence of foulants, pressure, operating flux, ionic strength, and stop-start interruptions, may have an impact on these parameters. Therefore, it is crucial to select and validate a virus filter that is appropriate for the anticipated range of conditions.
Pall has created robust, easy-to-use products for a variety of challenges. Pegasus SV4 and UltiPro VF Grade DV20 filters are the most compatible with the typical process design space for plasma processing requirements; Pegasus Prime filters and Pegasus Protect filters, on the other hand, are the best choice for meeting the requirements of MAb processing under a wide range of conditions.
Both options can be integrated into conventional stainless-steel processing lines as cartridges, or they can be integrated into pre-sterilized single-use manifolds as capsules.
PLASMA VIRUS FILTRATION SYSTEM MARKET SIZE AND FORECAST
The Global Plasma virus filtration system market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
PLASMA VIRUS FILTRATION SYSTEM MARKET NEW PRODUCT LAUNCH
The first filters designed specifically for the removal of plasma virus from biotherapeutic drug products like biopharmaceuticals and plasma derivatives were the Plan ova filters.
The international biopharmaceutical industry has relied on Plan ova filters for two decades for their safety and dependability. One of the leading filter manufacturers, Asahi Kasei Medical Co., Ltd., continues to expand its Plan ova TM filter production capacity to meet rising demand.
Plan ova filters combine scalability, validated virus safety, and high protein yield well. Size exclusion and depth filtration mechanisms underpin virus removability: Viruses that are larger than the average pore size are caught.
Plan ova filters come in a variety of pore sizes to meet the requirements of specific product applications for virus removal. A reliable scalability from development to large-scale manufacturing is achieved by using the same housing format and scaling the number of hollow fibers in each size filter.
PLASMA VIRUS FILTRATION SYSTEM MARKET COMPANY PROFILE
THIS PLASMA VIRUS FILTRATION SYSTEM MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |